Dr. Capeding led the first Phase 3 trial ever completed for a dengue vaccine candidate. The results of this trial in Asia (involving Sanofi Pasteur’s dengue vaccine candidate) were published this summer, July 11, in The Lancet.
If you are planning to travel abroad this month or in the months ahead, it is important to understand the health risks of the country you will be visiting. More than 125 million international tourists visit dengue endemic countries annually and are therefore at risk of infection, according to the World Tourism Organization of the United Nations.
In developing countries, over half a million children die from rotavirus every year and two million more are severely sickened or hospitalized, making rotavirus the leading cause of diarrhea deaths and illness worldwide.